Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID-19

Area of Science:

• Virology
• Molecular Biology
• Therapeutics

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, necessitates novel therapeutic strategies.
• Targeting viral components and essential host factors involved in viral replication is a key research focus.
• Nucleic acid-based technologies have emerged as potential antiviral treatments.

Purpose of the Study:

• To review the potential applications of antisense technology in treating coronaviruses, with a specific focus on COVID-19.
• To highlight the role of antisense technology in targeting viral and host factors crucial for SARS-CoV-2 infection.
• To explore various nucleic acid-based approaches for controlling SARS-CoV-2 and other respiratory viruses.

Main Methods:

• Literature review of existing research on antisense technology and its application in viral infections.
• Analysis of studies investigating nucleic acid-based therapies such as short interfering RNAs, antisense oligonucleotides, aptamers, DNAzymes, and ribozymes.
• Summarization of the therapeutic potential of antisense technology against coronaviruses.

Main Results:

• Antisense technology, including antisense oligonucleotides, shows significant promise for COVID-19 treatment.
• Down-regulating or silencing host factors utilized by SARS-CoV-2 can be an effective therapeutic strategy.
• Nucleic acid-based technologies have demonstrated potential in controlling SARS-CoV-2 and other respiratory viruses.

Conclusions:

• Antisense technology represents a viable and promising therapeutic avenue for managing coronavirus infections, including COVID-19.
• Further research and development in antisense-based strategies are warranted for effective COVID-19 treatment.
• The application of antisense technology extends beyond COVID-19, with potential benefits for other viral diseases.